mannosamine has been researched along with Rhabdomyosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, LA; Binder, B; Gallicchio, MA; Kaun, C; Wojta, J | 1 |
1 other study(ies) available for mannosamine and Rhabdomyosarcoma
Article | Year |
---|---|
Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Topics: Aprotinin; Cell Movement; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Hexosamines; Humans; Insulin-Like Growth Factor Binding Protein 6; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Mutation; Plasminogen Activator Inhibitor 1; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Rhabdomyosarcoma; Tissue Plasminogen Activator; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2003 |